Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.

Khoury P, Roufosse F, Kuang FL, Ackerman SJ, Akuthota P, Bochner BS, Johansson MW, Mathur SK, Ogbogu PU, Spencer LA, Wechsler ME, Zimmermann N, Klion AD, International Eosinophil Society Clinical Research Interest Group

Open source

DOI: 10.1093/jleuko/qiae051
Published: 2024 Jul 25
Container: Journal of leukocyte biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jleuko/qiae051,
  title = {Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.},
  author = {Khoury P and Roufosse F and Kuang FL and Ackerman SJ and Akuthota P and Bochner BS and Johansson MW and Mathur SK and Ogbogu PU and Spencer LA and Wechsler ME and Zimmermann N and Klion AD and International Eosinophil Society Clinical Research Interest Group},
  year = {2024},
  journal = {Journal of leukocyte biology},
  doi = {10.1093/jleuko/qiae051},
  url = {https://doi.org/10.1093/jleuko/qiae051}
}

RIS

TY  - JOUR
TI  - Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.
AU  - Khoury P
AU  - Roufosse F
AU  - Kuang FL
AU  - Ackerman SJ
AU  - Akuthota P
AU  - Bochner BS
AU  - Johansson MW
AU  - Mathur SK
AU  - Ogbogu PU
AU  - Spencer LA
AU  - Wechsler ME
AU  - Zimmermann N
AU  - Klion AD
AU  - International Eosinophil Society Clinical Research Interest Group
PY  - 2024
JO  - Journal of leukocyte biology
DO  - 10.1093/jleuko/qiae051
UR  - https://doi.org/10.1093/jleuko/qiae051
ER  -

APA

P, K., F, R., FL, K., SJ, A., P, A., BS, B., MW, J., SK, M., PU, O., LA, S., ME, W., N, Z., AD, K., & Group, I. E. S. C. R. I. (2024). Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.. Journal of leukocyte biology. https://doi.org/10.1093/jleuko/qiae051

Source records

pubmed · retrieved 2026-09-27T10:44:18.861Z
europe-pmc · retrieved 2026-09-27T10:44:18.865Z